(Hi The below was written few hours earlier, but could not be posted due to some network issues...so might overlapped with what you guys already said. Sorry! And haven't added the hidden population MadCow so rightly pointed out!)
Malaysian population ~33mil. About 6 mil below 12, so if we limit to inject just 12year old and above, that means 27mil. Suppose 3.5 mil receive the single dose Casino, then 27-3.5=23.5mil receive double-dose vaccines, so need 23.5*2+3.5=50.5 mil doses. So, we ordered 88/50.5~1.8 times of what we need. Now remember Singapore and other countries are talking about the need for 3rd shot as bolster, this means another 27mil doses. Now China has approved their vaccines for children as young as 3. I think Malaysian parents will also want their young children protected. We have ~5mil 3-12yrs old. So, another 10 mil doses (not counting bolster). Total needed: 50.5+27+10= 87.5mil doses. So are we ordering too many?
Now as many as hundreds of ppl dying by the day! Fast actual delivery is what we needed. No point order but late late delivery. Kanger has a contract with suggested delivery schedule stated.
@MatDangz. He He. Takut saya sendiri lupa. Maaflah ulang post yang sama dah banyak kali.
-----------------------
Kanger is still in progressing state in its current business, which are a bamboo flooring and related products, and Kanger also in its plan to venture in other business activities.
1. The company already involved in the construction services.
2. In a process to acquire property for investment.
3. In a process to acquire a company which involved in a construction material trading.
4. And of course a plan for Covid-19 vaccine business. Kanger is on the last step to procure 5 – 10 million doses of the Sinopharm vaccine for the sale in Malaysia.
I believe the booster shots will not be the same as the present ones. It would be new type to counter Delta or Lambda more effectively. No point using same one when the recipe is not effective.
cerita hantu ikan bilis termakan 18k mas tiruan... 1 bulan tak jadi pangsai, lepas jadi zombie ikan bilis... goreng tak mati, mulut keluar tahi... cerita macam ni baru best mar...
according to latest health expert report ...booster shots are required every 6 months...biotech is worth usd750 billion...will be worth usd 1 TRILLION or more...astronomical...
Singapore talking about booster shots around coming CNY. Most ppl worry about not enough vaccines, but some ppl here don't know why worry Malaysia will have oversupply!
KANGER enters deal to buy 5 million doses of SINOPHARM covid-19 vaccines for private use in MALAYSIA...biotech is worth usd750 billion...will be worth usd 1 TRILLION or more...
COLOMBO, July 20 (Xinhua) -- Researchers from one of Sri Lanka's leading universities, the Sri Jayewardenepura University, have found that China's Sinopharm COVID-19 vaccine is highly efficient against the Delta variant which has become the dominant variant across the world.
"This vaccine was found very effective for the Delta variant as well. The antibody responses to delta variant and neutralizing antibodies were similar to levels seen following natural infection," the University said on its website on Monday.
According to the study, 95 percent of individuals who received two doses of the Sinopharm vaccine have developed antibodies similar to a naturally infected COVID-19 person.
The study showed that two doses of Sinopharm vaccine produced neutralizing antibodies in 81.25 percent of recipients and that these antibody levels were similar to what would occur after surviving a natural infection of COVID-19.
The research team included Sri Lankan scientists Prof. Neelika Malavige, head of the Immunology and Molecular Medicine Department of the Sri Jayewardenepura University, her colleague Dr. Chandima Jeewandara and Oxford University researchers Prof. Graham Ogg and Prof. Alain Townsend.
Prof. Neelika told Xinhua that Sinopharm is the most used vaccine being rolled out in Sri Lanka presently due to the availability of stocks in the country.
To date, 4.63 million people in Sri Lanka have received the first dose of Sinopharm COVID-19 vaccine, and 1.29 million others had received the second dose of the vaccine. No single severe side effect case relevant to the vaccine has been reported.
Prof. Malavige said this study is the first of its kind to be published in the world and experts looked at every possible angle of the immune system from the Sinopharm jab.
The vaccine was also compared to the Alpha and Beta variants of the virus as well as the original virus.
"The conclusion of this report is that when it comes to Delta and other variants, the Sinopharm vaccine induces similar levels of antibody responses as people who have naturally been infected, Which is very good," Prof. Malavige said.
"Between the age groups of 20 to 40, 98 percent developed antibodies while in the age group of over 60, 93 percent developed antibodies. This is not surprising as older people respond less to vaccines," the Professor added.
She said this data on the Sinopharm did not turn up to the world before, and such real-world data was important to build up vaccine confidence domestically and internationally. Enditem
@olangbolo. Tak nak beli tk apa. Tak ada siapa yang suruh beli atau larang beli. Nanti bila orang cerita beberapa kali, pancut awak beri komen macam dengki jeee...
olangbolo.....org kalau level pancut banyak kali, xde mcm ko.. that call DAY TRADeRs.. ----------------- MZM2511 @18Kharmoni............. Separuh main kontra. Separuh simpan untuk medium term bagi tujuan RI. He He
sb itu ko bodo sombong, anal ysis mcm "due deligence".. tulis panjang lebar from NPRA Buloh Construction vaccine RI etc .. that yr target for gross profit 3sen... hahhaaha... finally its reveal who u r..
the way ko punya anal ysis mcm la this counter can be like Bintai..
thx.. finally u trap yself.. kalau org menipu ni senang nak kantoi..
No wonder u plomoter for " bumi market" hahahahaha.. bolooo sgt
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Peace99
2,264 posts
Posted by Peace99 > 2021-07-24 18:28 | Report Abuse
(Hi The below was written few hours earlier, but could not be posted due to some network issues...so might overlapped with what you guys already said. Sorry! And haven't added the hidden population MadCow so rightly pointed out!)
Wenger, thanks for your alert.
I estimated ~88mil doses of vaccines ordered, based on recent news on Pharmaniaga and article below:
https://my.asiatatler.com/life/vaccines-in-malaysias-covid-vaccination-programme-pfizer-astrazeneca-sinovac-cansinobio-sputnik-v
Sinovac~27mil, AZ~14, Pfizer~32, Casino~3.5, Sputnik V~6.5, Sinopharm(Kanger ordered)~5
27+14+32+3.5+6.5+5=88mil. OK, may be miss several mil more because not yet count Dpharma.
Malaysian population ~33mil. About 6 mil below 12, so if we limit to inject just 12year old and above, that means 27mil. Suppose 3.5 mil receive the single dose Casino, then 27-3.5=23.5mil receive double-dose vaccines, so need 23.5*2+3.5=50.5 mil doses. So, we ordered 88/50.5~1.8 times of what we need. Now remember Singapore and other countries are talking about the need for 3rd shot as bolster, this means another 27mil doses. Now China has approved their vaccines for children as young as 3. I think Malaysian parents will also want their young children protected. We have ~5mil 3-12yrs old. So, another 10 mil doses (not counting bolster). Total needed: 50.5+27+10= 87.5mil doses. So are we ordering too many?
Now as many as hundreds of ppl dying by the day! Fast actual delivery is what we needed. No point order but late late delivery. Kanger has a contract with suggested delivery schedule stated.
Is Kanger not doing the right thing?